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Abstract: Quality healthcare outcomes depend upon patients’ adherence to recommended
treatment regimens. Patient nonadherence can be a pervasive threat to health and wellbeing
and carry an appreciable economic burden as well. In some disease conditions, more than
40% of patients sustain significant risks by misunderstanding, forgetting, or ignoring healthcare
advice. While no single intervention strategy can improve the adherence of all patients, decades
of research studies agree that successful attempts to improve patient adherence depend upon
a set of key factors. These include realistic assessment of patients’ knowledge and understanding
of the regimen, clear and effective communication between health professionals and their
patients, and the nurturance of trust in the therapeutic relationship. Patients must be given the
opportunity to tell the story of their unique illness experiences. Knowing the patient as a
person allows the health professional to understand elements that are crucial to the patient’s
adherence: beliefs, attitudes, subjective norms, cultural context, social supports, and emotional
health challenges, particularly depression. Physician–patient partnerships are essential when
choosing amongst various therapeutic options to maximize adherence. Mutual collaboration
fosters greater patient satisfaction, reduces the risks of nonadherence, and improves patients’
healthcare outcomes.
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Introduction
For most medical conditions, correct diagnosis and effective medical treatment are
essential to a patient’s survival and quality of life. A significant barrier to effective
medical treatment, however, is the patient’s failure to follow the recommendations
of his or her physician or other healthcare provider. Patient nonadherence (sometimes
called noncompliance) can take many forms; the advice given to patients by their
healthcare professionals to cure or control disease is too often misunderstood, carried
out incorrectly, forgotten, or even completely ignored. Nonadherence carries a huge
economic burden. Yearly expenditures for the consequences of nonadherence have
been estimated to be in the hundreds of billions of US dollars (DiMatteo 2004b).
Estimates of hospitalization costs due to medication nonadherence are as high as
$13.35 billion annually in the US alone (Sullivan et al 1990). In addition to the most
obvious direct costs, nonadherence is also a risk factor for a variety of subsequent
poor health outcomes, including as many as 125 000 deaths each year (Smith 1989;
Burman et al 1997; Christensen and Ehlers 2002; Kane et al 2003).
The corpus of literature on patient adherence is large, and there are many
conceptual models that attempt to integrate a large number of complex factors that
affect adherence (Bowen et al 2001). To manage the size and complexity of the
empirical findings of this massive research enterprise, reliance on meta-analytic work
is necessary to provide the building blocks for data-driven models of patient adherence.
Currently, ongoing meta-analytic studies at the University of California, Riverside,
USA, are beginning to identify a number of stable and consistent factors that affect
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of the literature, along with new empirical advances,
highlight the complexities inherent in understanding and
effecting changes in patient adherence and suggest solutions
to common problems in medication management. Much that
has been learned from recent research on the communication
between healthcare providers and their patients can lessen
the economic burden of nonadherence and improve
healthcare processes and outcomes for patients.
Overview
Research during the past several decades indicates that,
depending upon their conditions and the complexity of the
regimens required, as many as 40% of patients fail to adhere
to treatment recommendations (DiMatteo and DiNicola
1982; DiMatteo 1994, 2004a, 2004c; Lin et al 1995; Rizzo
and Simons 1997; Dunbar-Jacob et al 2000; Laederach-
Hofmann and Bunzel 2000; Haddad et al 2004; Haynes et
al 2004). When preventive or treatment regimens are very
complex and/or require lifestyle changes and the
modification of existing habits, nonadherence can be as high
as 70% (Dishman 1982, 1994; Brownell and Cohen 1995;
Katz et al 1998; Chesney 2000; Li et al 2000). Although
patients with HIV/AIDS may be highly motivated to adhere,
their medication regimens are particularly complex, often
involving multiple drug “cocktails” (Catz et al 2000;
Heckman et al 2004).
Studies exploring simple versus complex dosing
schedules have found that adherence falls off appreciably
when regimens become more complicated and affect
patients’ lifestyles (Chesney 2003). For example, the number
of medications to be taken per day can have a significant
influence, with adherence rates dropping to as low as 20%
among patients who must take thirteen or more pills each
day (Graveley and Oseasohn 1991). In one study of patients
with hypertension, adherence to a thrice-daily medication
regimen was only 59% compared with about 84% for a once-
daily regimen (Eisen et al 1990). In another study of patients
with severe persistent asthma, only 32% adhered to a
regimen that included multiple components such as inhaled
and systemic corticosteroids and long-acting broncho-
dilators (Barr et al 2002).
Adherence to recommendations involving lifestyle
changes such as exercise frequently poses significant
difficulties for patients. For example, those with chronic
illnesses in the Medical Outcomes Study had average
adherence rates to exercise regimens of only 19% (Kravitz
et al 1993). In another study involving a physical therapy
exercise regimen, only 35% of patients adhered fully; 76%
followed their prescribed regimen partly but not wholly
(Sluijs et al 1993). Such programs, of course, tend to be
more successful in supervised rather than home-based
programs (McKelvie et al 2002).
The health consequences of nonadherence can be quite
severe. Nonadherence compromises patient outcomes in
many different ways but is most obvious when patients fail
to take medications that likely would cure or at least
effectively manage their illnesses (Miller 1997; Chesney et
al 2000; Weir et al 2000). For HIV patients who are not at
least 90%–95% adherent, viral replication and consequent
disease progression may result (Catz et al 2000; Hinkin et
al 2002). For patients suffering from or those at risk of
coronary heart disease, nonadherence to medication
treatments can jeopardize survival (McDermott 1997).
Among diabetic patients, adherence to medication for
controlling hypertension is essential to preventing mortality
from diabetes and myocardial infarction (Elliott et al 2000).
Further, aside from direct biomedical benefits, studies show
that health may depend partly upon the act of adhering to a
regimen. Some research suggests that adherence, even to a
placebo, is itself beneficial to health outcomes (McDermott
1997; Irvine et al 1999).
The clinical picture in a patient’s treatment can also be
confused by nonadherence with patients’ risk profiles
increased as a result. When physicians erroneously assume
that their patients have taken prescribed medication(s), they
may make inappropriate medication and/or dosage changes,
which can then result in further complications and
suboptimal health outcomes. Thus, not only do nonadherent
patients fail to benefit from effective medication, they also
risk being harmed by less than ideal medication and dosage
choices (Joshi and Milfred 1995; Salzman 1995; Bedell et
al 2000). Relatedly, the risk of new illness may increase in
the context of nonadherence, such as when antibiotic-
resistant bacterial infections develop because patients have
not taken their full, prescribed doses of antibiotics (Harrison
1995; Lutfey et al 1996; Graham 1998; Rao 1998;
Raviglione et al 2001). Thus, it is clear that nonadherence
often results in a combination of wasted medical care dollars
(Johnson and Bootman 1995; Rizzo and Simons 1997;
DiMatteo 2004b), wasted time and energy for patients and
healthcare providers alike (DiMatteo et al 1994), and
frustration and dissatisfaction for all interactants.
Research on patient adherence
The research literature on patient adherence is extensive.
Over the past 50 years, there have been 32 550 adherence-Therapeutics and Clinical Risk Management 2005:1(3) 191
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related citations in PubMed and 10 087 in PsychLit. Of these
citations, more than 2000 represent empirical research
articles that involved the assessment of medical patients’
adherence to a variety of physician-prescribed regimens
(medication, diet, exercise, lifestyle changes, etc).
In this research, as in clinical practice, adherence is
measured in a variety of ways including pill counts; self-
reports or patient diaries; physician reports; reports by others
(such as the patient’s spouse); electronic measures (eg,
metered dose inhalers or electronic recordings of dispensed
eye drops); blood or urine assays; medical record/chart and
pharmacy records; and biologic markers (Farmer 1999).
These various methods are used in the context of a vast array
of disease conditions both chronic and acute. Assessment
methods differ in their degree of subjectivity and
sophistication, ranging from simple self-reports to more
technologically-oriented tools such as the Medication Event
Monitoring System (MEMS)
™ – an innovative method for
measuring adherence in which a hidden microchip
mechanism records the time and date that a patient opens a
pill box, removes a pill from a pack, actuates an inhaler, or
dispenses an eye drop (Farmer 1999). With technologies
such as these, every removed dose of medication sends an
electronic signal to the physician with the date and time the
bottle was opened (Eisen et al 1990), providing a very
reliable indicator of medication access (despite the
remaining possibility that the dose was removed but not
actually taken as prescribed). Direct observation of a patient
taking medication is another, albeit more energy-intensive,
method for assessing adherence (Volmink et al 2000). In
the treatment of latent tuberculosis infection, for example,
measurement of adherence to isoniazid (INH) can be direct,
using an assessment of INH metabolites in patients’ urine
(Perry et al 2002; Eidlitz-Markus et al 2003). Pharmacy
records represent another resource for measuring adherence.
Recent studies have analyzed pharmacy claims databases
involving large numbers of patient records and indicating
such data as when the medication was obtained and whether
prescriptions were refilled on schedule (Tai-Seale et al 2000;
Bieszk et al 2003).
Understanding adherence requires a multi-method
approach to give a clear and accurate picture of whether
and how medical recommendations are being followed.
Adherence needs to be measured using multiple tools. For
example, adherence to antidepressant medication might be
assessed by pill count, patient self-report, and MEMS
(Thompson et al 2000; Hamilton 2003). The combination
and reconciling of various assessment techniques can be
quite valuable, as individual measures of adherence have
been shown to differ from one another by as much as 37%
(Milgrom et al 1996).
Just as studies of adherence vary greatly in the way they
measure the construct, they also range widely in scope and
application. Some studies focus on variations in rates of
nonadherence (DiMatteo 2004c), some on particular types
of nonadherence and their associations with patient
outcomes (DiMatteo 2002), others on the correlates of
adherence (DiMatteo 2000, 2004a), and still others on the
ways clinicians can improve adherence rates for their
patients (Roter et al 1998; Atreja et al 2005). Meta-analytic
techniques are now being used as well (Macharia et al 1992;
DiMatteo et al 2000, 2002; McDonald et al 2002; Peterson
2003; Ismail 2004). Their goal is to synthesize and
summarize what we currently know about adherence and to
develop data-driven models for understanding the
phenomenon and initiating interventions. Such an approach
requires careful organization and assessment of the research
findings on adherence, seeking evidence for convergence,
and stability in research findings. It is clear from the research
to date that as we compile and analyze the empirical
evidence on patient adherence, we approach an enhanced
understanding of this complex and important issue. In this
article, we review some of the most robust findings on patient
adherence, identifying what we currently know about how
to manage and reduce its associated clinical risks in the
context of medical practice, as well as what we have yet to
determine.
Factors that affect adherence
Cognitive factors
It goes without saying, perhaps, that patients must
understand what they are supposed to do before they can
follow medical recommendations. Thus, patients’ health
literacy is central to their ability to adhere. According to
Healthy People 2010, health literacy involves the “degree
to which individuals have the capacity to obtain, process,
and understand basic health information and services needed
to make appropriate health decisions” (US DHHS 2000,
p 20). Studies show that the risk of nonadherence is very
high when patients cannot read and understand basic written
medical instructions. Misunderstanding of this type is not
as uncommon as one might imagine. One large study of
over 2500 patients found that nearly one third had marginal
or inadequate health literacy. Of these, 42% misunderstood
directions for taking medications on an empty stomach,
25% misunderstood the scheduling of their nextTherapeutics and Clinical Risk Management 2005:1(3) 192
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appointment, and nearly 60% were unable to read and
understand a typical informed consent document (Williams
et al 1995). Language barriers contributed somewhat to these
limitations, but even when patients could understand the
language of their medical instructions, many could not
comprehend the medical information. Further, older patients
in this study had significantly more problems understanding
their medical regimens than did younger patients. Other
studies confirm these trends and indicate that our current
interventions aimed at increasing health literacy to improve
patient adherence have, so far, been disturbingly ineffective
(Williams et al 1998; Gazmararian et al 1999; Schillinger
et al 2003).
Patients’ health beliefs are affected by their health
literacy, and these beliefs are also contributors to
(non)adherence. In a study of asthmatic patients who were
given extensive, high-quality information on the use of daily
inhaled corticosteroids, only 38% adhered to their
medication regimen, whereas the other 62% continued to
mistakenly believe that their medication should only be taken
when they were symptomatic (Anarella et al 2004). In
practice, patients’ low health literacy has been linked to
ineffective physician–patient communication and, in
particular, physicians’ failure to assess recall and
comprehension of new concepts with their patients
(Schillinger et al 2003). Low health literacy has been
associated with patient depression (Kalichman 1999) and
consequently with the manner in which patients
communicate with their doctors. Patient health literacy issues
may also be tied to ethnic disparities in screening, such as
mammography, probably because of reduced access to and
understanding of written cancer prevention materials (Peek
and Han 2004).
Another important factor influencing nonadherence is
patients’ ability to remember the details of the recom-
mendations made to them. Studies have repeatedly shown
that forgetting to take (or how to take) medications is a major
contributor to nonadherence (Kravitz et al 1993; Cline et al
1999; Brekke et al 2004; Shemesh et al 2004; Zaghloul and
Goodfield 2004). Even when information is communicated
effectively and comprehension is initially high, much of
what is conveyed during the medical visit is forgotten within
moments of leaving the doctor’s office. One study found
that patients forgot 56% of their instructions shortly after
leaving the clinic (Ley and Spelman 1965). Optimal verbal
communication often does not exist, and the verbal
communication between physicians and patients is often
filled with technical terms and “medical jargon” that impedes
patients’ comprehension and retention of information
(Jackson 1992). In the interest of time efficiency, details of
the prescribed treatment may not be thoroughly explained
and/or rehearsed with patients (Stanton 1987), but such
clarification is necessary. Healthcare providers need to
explain the specific steps of the regimen, review the most
important details, use written instructions, and encourage
their patients to ask questions about the regimen for
adherence to occur (Becker and Maiman 1980; Carter et al
1982; Wolf 1988; Frank et al 1997).
Not surprisingly, when patients are presented with a very
large amount of information, they tend to forget a large
proportion of it (Ley 1979; Rost et al 1990). High anxiety
also contributes to patients’ lower levels of recall, and
increases the risk of nonadherence (Ley 1979; Shapiro et al
1992; Montgomery 1999). On the other hand, research
suggests that the risk of nonadherence is reduced when
patients know their doctors well and are in more familiar,
and less anxiety-provoking, physician–patient relationships
(Rost et al 1990; Heffer et al 1997). Finally, it has been
shown that when patients are more satisfied with their
medical visits, they tend to experience better recall of
information (Falvo and Tippy 1988). Empathic com-
munication involving a thorough understanding of the
patient’s perspective, improves adherence. Patients who are
informed and affectively motivated are also more likely to
adhere to their treatment recommendations (Squier 1990).
These findings illustrate the importance of the “psychosocial
elements” in the medical encounter and their contribution
to improving patient adherence to treatment.
Interpersonal factors
The interpersonal dynamics of the physician–patient
relationship play an important role in determining a variety
of patient outcomes including patient adherence to their
treatment recommendations. Patients who feel that their
physicians communicate well with them and actively
encourage them to be involved in their own care tend to be
more motivated to adhere (Frankel 1995; Safran et al 1998;
Martin et al 2001; O’Malley et al 2002). Additionally, when
physicians and patients agree on how involved patients
should be in their care, adherence is improved (Jahng et al
2005). Cohesive partnerships and effective interpersonal
communication make it possible for patients and physicians
to work together to help patients follow mutually agreed-
upon recommendations (Jahng et al 2005). SuccessfulTherapeutics and Clinical Risk Management 2005:1(3) 193
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communication between physicians and patients promotes
greater patient satisfaction with medical care, which in turn
fosters higher levels of adherence.
Patients’ trust in their physicians is essential to their
emotional disclosure and is therefore a crucial component
of the patient–physician relationship. Patients must believe
that their physician is someone who can understand their
unique experience of being a patient, and someone who can
provide them with reliable and honest advice (Branch 2000).
Trusting relationships between physicians and patients can
greatly affect patient outcomes. For example, it has been
shown that physicians who promote trust in the therapeutic
relationship, who have effective communication and
“bedside manner”, and who express compassion for their
patients succeed in fostering cooperation and patient
adherence with a variety of preventive and treatment
recommendations (O’Malley et al 2002). Adherence rates
have been found to be nearly 3 times higher in primary care
relationships characterized by very high levels of trust
coupled with physicians’ knowledge of the patient as a whole
person. In fact, patients’ trust in their physician has been
found to far exceed many other variables when it comes to
promoting patients’ satisfaction with their care (Safran et al
1998).
Patient involvement and participatory
decision making
Studies have found that both patient satisfaction and patient
adherence are enhanced by patients’ involvement and
participation in their care (Martin et al 2001, 2003). The
behavior of physicians and patients tends to be reciprocal
when they strive toward partnership. Patients who want to
be more involved tend to ask more questions and display
more confidence, and physicians who are willing to sustain
collaborative relationships with their patients tend to act in
ways that prompt their patients to be involved and active
(Street et al 2003). Research has also shown that patients
who participate in discussions of behavioral strategies with
their doctor are more likely to adhere to antidepressant
medication (Lin et al 1995). Physician–patient partnership
and social support from health professionals, as well as from
members of the patient’s social network, are essential to
patients’ adherence to recommended treatments (DiMatteo
et al 1994; DiMatteo 2004a, 2004c).
This reciprocity and mutuality between patients and their
physicians is sometimes termed concordance and is key to
greater patient involvement in decision making. When health
professional–patient relationships are concordant, patients
understand the costs and benefits of their recommended
regimens, and through a process of negotiation with their
physicians they arrive at a better understanding of treatment.
When physicians and patients work together and strive for
mutual agreement, they both achieve higher levels of
satisfaction with the treatment encounter (Elwyn et al 2003).
This reciprocal exchange of information is vital to the
decision making process that actively involves the patient
(eg, Ong et al 1995). Patients tend to be more satisfied with
such exchanges and take more responsibility for and adhere
better to treatment choices that are made jointly. Even when
dealing with a serious illness such as cancer, most patients
have been found to desire all possible information regarding
their condition and treatment, even if that information is
initially emotionally disturbing to them (Hogbin and
Fallowfield 1989; Chaitchik et al 1992). The health
professional’s willingness to enter this discussion and
process of negotiation with patients is critical to subsequent
outcomes.
Patients’ attitudes
Patients’ understanding of their recommendations and good
physician–patient relationships are, of course, not sufficient
to eliminate the risk of nonadherence. Patients’ attitudes,
beliefs, and group norms all influence adherence in
meaningful and sometimes complex ways. Various cognitive
and behavioral models, such as the Theory of Reasoned
Action (Ajzen and Fishbein 1980), the Theory of Planned
Behavior (Ajzen 1985), and the Transtheoretical Model of
Change (Prochaska and DiClemente 1984) demonstrate that
people’s intentions to carry out a behavior, such as to follow
medication treatment, are the immediate precursors to the
behavior itself. In other words, intending to adhere, whether
this is labeled an intention, a readiness, or a stage of change,
is essential to following treatment advice (McCusker et al
1994; Prochaska and Velicer 1997; Willey et al 2000;
Hannover et al 2002; Blanchard et al 2003; Anatchkova et
al 2005). Intentions, in turn, depend upon what people think
and believe, what attitudes they hold, and how other people
influence them. Thus, if patients hold beliefs that are
incongruent with what their physicians prescribe for them,
or if their family or social group members hold divergent
views about their illnesses and treatments, patients may have
difficulty even forming a willingness or intention to adhere
(Greenfield et al 1987; Myers et al 1999; Soliday and
Hoeksel 2000; Straughan and Seow 2000). The socialTherapeutics and Clinical Risk Management 2005:1(3) 194
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environment and the social support available to patients also
affect their willingness to adhere, especially when dealing
with such conditions as depression, anxiety, HIV, and other
illnesses that carry a potential stigma (Roter and Hall 1992;
Bensing et al 1995; Kadam et al 2001; Sirey et al 2001).
Cultural variations
Of course, the best way for physicians to facilitate their
patients’ involvement in care varies across cultures
(Calderón and Martin 2003). Preliminary results from our
ongoing studies with several ethnic groups in Indonesia
demonstrate that interventions aimed at increasing
adherence require a multifaceted approach and sophisticated
understanding of the complexity of issues involved.
Guidelines for improving patient adherence must be tailored
to the cultural backgrounds of the individual patients.
Although some research has shown positive correlates and
outcomes of partnerships when patients and physicians are
of the same ethnic background (Cooper-Patrick et al 1999;
Saha et al 1999; Cooper et al 2003) other studies have failed
to demonstrate this effect and suggest that matching
physicians and patients according to their ethnicity is not
necessary (eg, Jahng et al 2005). Certainly constructs such
as ethnicity, age, and gender are not unimportant, but they
interact in very complex ways and may not be as important
as communication factors. Recent evidence suggests that
physician–patient congruence on their preferences for
patient involvement in care is more important than
congruence on demographic variables such as ethnicity, age,
or gender (Jahng et al 2005). This study evaluated each of
these demographic characteristics and found that congruence
in preferences for patient involvement was the only
significant predictor of self-reported patient adherence,
accounting for approximately one fourth of the variance;
similarity in age or being of the same ethnicity or gender
were unrelated to adherence. These findings illustrate the
importance of discussing the physician–patient partnership
and together negotiating the patient’s role, and suggest that
communication (both verbal and nonverbal), partnership and
participation, behavior modification strategies, and the
prompts and reminders that encourage adherence should
be developed uniquely for each individual patient.
In addition to attitudes and sociocultural norms, patients’
perceptions of their physicians are also very good predictors
of patients’ intentions to adhere. In a study we are currently
conducting in conjunction with the Bayer Institute for Health
Care Communication, our preliminary findings suggest that
(in a US sample) patients’ intentions to adhere to their
recommended treatments are significantly correlated with
having choices regarding medical treatments; having the
opportunity to discuss their care with their physicians;
having their preferences taken into account; and having a
doctor who communicates well (all significant at p < 0.001).
In addition, preliminary data confirm and extend previous
research showing that the amount of trust patients have in
their physicians is a strong predictor of whether they plan
to carry out treatment recommendations.
Depression
In meta-analytic work, findings suggest that one of the
strongest predictors of patient nonadherence to medical
treatment is patient depression (DiMatteo et al 2000). The
risk of patient nonadherence is 27% higher if a medical
patient is depressed than if he or she is not (it is 30% higher
if that patient has end-stage renal disease). Depression has
long been known to predict poor health outcomes, a fact
that may be explained partly by the adherence problems
caused by depression. Depressed patients experience
pessimism, cognitive impairments, and withdrawal from
social support, all of which can diminish both the willingness
and ability to follow treatment regimens.
Depression is a prevalent and powerful factor in health
and illness, and one that cannot be ignored. It is associated
with impairment equal to or greater than that of chronic
recurrent disorders such as diabetes, hypertension, arthritis,
and emphysema (Wells et al 1988, 1989). Depression is
currently the most prevalent mental illness and a cause of
immense disability in industrialized countries. Major
depression is second only to coronary heart disease in
functional limitations and serious role impairment (Murray
and Lopez 1997; Frasure-Smith and Lespérance 2005).
Depression has been cited as the most common clinical
problem that primary care physicians are called upon to
diagnose and treat. In a given year, in primary care settings,
up to 20% of adults present with depression (and often
comorbid anxiety) (Greenburg et al 1993; Kirmayer et al
1993).
Psychological disorders are often comorbid with chronic
illnesses, increasing their associated morbidity and mortality
rates (Brody et al 1995; Waldron 1999; Frasure-Smith and
Lespérance 2005). These conditions, however, often go
untreated (Young et al 2001). Primary care physicians fail
to diagnose as many as 50%–70% of persons who present
with current depressive disorder (Higgins 1994; Coyne etTherapeutics and Clinical Risk Management 2005:1(3) 195
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al 1995; Lecrubrier 1998; Williams et al 1999; Ballenger et
al 2001) despite the potential harm to patients’ adherence
and health. Even when depression is recognized, it is
diagnosed and treated accurately only 30%–40% of the time
(Farmer and Griffiths 1992; Kirmayer et al 1993; Rost et al
1994). In the Medical Outcomes Study, 60% of patients with
major depression received no medication at all (Wells et al
1994; Sturm et al 1995). Thus, the opportunity to manage
major risk factors for nonadherence and for serious patient
morbidity and mortality is often missed in primary care.
Why does such a serious risk factor for nonadherence
(and other poor healthcare outcomes) so often go
unrecognized in the primary care medical interaction?
Research suggests that both patients and their physicians
contribute jointly to this problem in the medical interaction.
Patient factors that prevent recognition of depression in
primary care include lack of awareness and understanding
of depression symptoms, complaints of physical symptoms
that take precedence or confuse the clinical picture, and
failure to admit to psychological symptoms because they
fear a stigma of mental illness (Docherty 1997). Patients
may be reluctant to talk about non-medical matters because
they expect physician disinterest or the risk of
embarrassment, or because of anxiety about the possible
significance of their psychological symptoms (Roter and
Hall 1992).
Physician factors can also interfere with the recognition
of depression in primary care settings. These include lack
of knowledge about the disease, lack of training in the
management of depression, reluctance to inquire about their
patients’ emotional states, and limited time available for
patients (Docherty 1997; Carney et al 1999). Indeed,
patients’ health status can influence the degree of interest
and responsiveness they receive. Physicians have been found
to convey greater negativity toward physically or mentally
less healthy patients and to act more positively toward
healthier ones (Hall et al 1996).
Despite many barriers to recognition and treatment,
depression continues to play a central role in nonadherence.
Appreciation of the importance of patients’ mental health
in the care of their acute and chronic medical conditions
can help to reduce the risks of nonadherence and contribute
to more positive health outcomes (Ballenger et al 2001).
New and developing models of depression management
in primary care show great promise for improving
patient commitment to and ultimately the success of
medical treatments.
Improving patient adherence
The first step toward improving patient adherence involves
accurately assessing whether or not patients have followed
the treatments recommended to them. The precise estimation
of patient adherence is not easy, and a full understanding of
whether and why any given patient chooses and is able to
adhere is often elusive. Physicians are typically not well
informed about their patients’ adherence, and reliance upon
their own intuition or upon attempts to “catch” their patients
in nonadherence can be quite problematic. Patients tend to
be truthful in their adherence reports only when they feel
free to admit adherence difficulties without the risk of
criticism and in the context of true partnership with their
physicians (Haug and Lavin 1981; Hays and DiMatteo
1987). The accurate assessment of adherence depends, to a
large degree, on the development of a trusting and accepting
relationship between the patient and the healthcare team.
Adherence assessments that are simple (presenting as little
burden to the respondent as possible) and nonthreatening
will also likely yield the most honest and accurate responses.
Realistic assessment of patients’ knowledge and
understanding of the regimen, and their belief in it, will
enable a more effective targeting of the potential for
adherence problems. Many of the factors necessary to carry
out such assessment are the very elements that foster
communication and partnership in the medical visit. Patients
need to be given the opportunity to tell their story (Mishler
1984; Smith and Hoppe 1991; Roter and Hall 1992; Roter
2000; Haidet and Paterniti 2003) and to present their point
of view to the physician. From this, much information about
patients’ beliefs, attitudes, subjective norms, cultural
contexts, social supports, and emotional health challenges
(particularly depression) can be learned. These elements are
central to the establishment of adherence intentions, and
must be explored and discussed in the therapeutic
relationship. Perfect agreement will not always be reached,
and in fact may not be desirable. Some degree of conflict
between the views of physician and patient may be necessary
if truly adult collaboration is to take place and a variety of
therapeutic options, and ways to adhere to them, jointly
considered (Katz 1984; Wolf 1988). The acknowledgment
of differences is an important part of building respectful
and trusting relationships between physicians and their
patients.
No single intervention strategy can improve the
adherence of all patients (Hamilton et al 1993; Cheng et al
1997; Roter et al 1998). Success depends upon tailoringTherapeutics and Clinical Risk Management 2005:1(3) 196
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interventions to the unique characteristics of patients, disease
conditions, and treatment regimens (McDonald et al 2002).
For example, some patients may be unable to maintain a
complicated regimen without a strong system of social
support and many prompts to remind them of what needs to
be done. Other patients may have problems keeping
appointments because they do not have access to reliable
transportation or because family emergencies arise. Still
others may find that side effects of medications are
prohibitive or they may simply be unmotivated. The
healthcare provider must be attuned to the individual,
picking up on subtle hints (verbal and nonverbal) that the
patient may express. A flexible mindset in which the
physician thinks creatively about treatment options is always
an asset. The physician–patient partnership itself, however,
remains at the core of all successful attempts to improve
adherence behaviors. Participation, engagement,
collaboration, negotiation, and sometimes compromise
enhance opportunities for optimal therapy in which patients
take responsibility for their part of the adherence equation.
These partnerships foster greater patient satisfaction,
improved patient adherence, and ultimately optimal
healthcare outcomes.
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